Canton Strategic Holdings (CNTN) Cash from Investing Activities (2026)
Canton Strategic Holdings (CNTN) posted Cash from Investing Activities of -$54.8 million for Q1 2026.
Canton Strategic Holdings (CNTN) Cash from Investing Activities (2026) Analysis & Trends
Canton Strategic Holdings' Cash from Investing Activities history runs 1 years deep, the most recent figure standing at -$54.8 million for Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,015.37 Bn | 1,015.37 Bn | - | - |
| 4 | BeOne Medicines | 471.39 Bn | 466.59 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 122.52 Bn | 115.28 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 70.33 Bn | 61.58 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Canton Strategic Holdings | 430.99 Mn | 430.99 Mn | - | -54.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54.82 Mn |
| Mar 31, 2026 | -54.82 Mn |